119 related articles for article (PubMed ID: 12803133)
1. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neutropenia in a renal transplant recipient with granulocyte colony-stimulating factor.
Moghal NE; Milford DV; Darbyshire P
Pediatr Nephrol; 1998 Jan; 12(1):14-5. PubMed ID: 9502559
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.
Scagni P; Saracco P; Timeus F; Farinasso L; Dall'Aglio M; Bosa EM; Crescenzio N; Spinelli M; Basso G; Ramenghi U
Haematologica; 1998 May; 83(5):432-7. PubMed ID: 9658728
[TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
[No Abstract] [Full Text] [Related]
6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
7. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
Peddi VR; Hariharan S; Schroeder TJ; First MR
Clin Transplant; 1996 Feb; 10(1 Pt 1):20-3. PubMed ID: 8652892
[TBL] [Abstract][Full Text] [Related]
8. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System.
Hurst FP; Belur P; Nee R; Agodoa LY; Patel P; Abbott KC; Jindal RM
Transplantation; 2011 Jul; 92(1):36-40. PubMed ID: 21512429
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of granulocyte colony-stimulating factor: an update and summary.
Hübel K; Engert A
Ann Hematol; 2003 Apr; 82(4):207-13. PubMed ID: 12707722
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection.
Rewerts JM; McCaw DL; Cohn LA; Wagner-Mann C; Harrington D
J Am Vet Med Assoc; 1998 Oct; 213(7):991-2. PubMed ID: 9776994
[TBL] [Abstract][Full Text] [Related]
12. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
Shochat E; Rom-Kedar V
Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with "idiopathic neonatal neutropenia": a randomized, placebo-controlled trial.
Juul SE; Christensen RD
J Perinatol; 2003 Sep; 23(6):493-7. PubMed ID: 13679938
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.
Carulli G; Lazzeri E; Lagomarsini G; Zucca A; Cannizzo E; Riccioni R; Petrini M
Clin Ter; 2007; 158(3):235-7. PubMed ID: 17612284
[TBL] [Abstract][Full Text] [Related]
15. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
[TBL] [Abstract][Full Text] [Related]
17. [Granulocyte colony-stimulating factor in the newborn neutropenic patient].
Castillo Salinas F; Díaz de Heredia Rubio C; Salcedo Abizanda S; Ferrer Comalat A; Bastida Vila P; Ortega Aramburu JJ; Peguero Monforte G
An Esp Pediatr; 1998 Dec; 49(6):615-8. PubMed ID: 9972625
[TBL] [Abstract][Full Text] [Related]
18. Severe chronic neutropenia--a case report.
Bahl S; Vurgese T; Parappil A
Indian J Pathol Microbiol; 2004 Oct; 47(4):523-5. PubMed ID: 16295383
[TBL] [Abstract][Full Text] [Related]
19. [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia].
Kahl C; Leithäuser M; Freund M
Dtsch Med Wochenschr; 2002 Jul; 127(27):1473-8. PubMed ID: 12098099
[No Abstract] [Full Text] [Related]
20. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.
Wang S; Degar BA; Zieske A; Shafi NQ; Rose MG
Am J Hematol; 2004 Dec; 77(4):391-6. PubMed ID: 15551287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
